Risk of neurologicalcomplications (0 to 30 days) · adults undergoing cardiac surgery without cardiopulmonary bypass
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pulmonary complications (0 to 30 days) · adult cardiac surgical patients
Epidural analgesia showed no clear difference in pulmonary complications (0 to 30 days) compared with systemic analgesia (low certainty).
1 finding from 1 review
Neurological complications · adult cardiac surgical patients
It is very uncertain whether epidural analgesia changes risk of neurological complications (0 to 30 days) compared with systemic analgesia (very low certainty).
1 finding from 1 review
Mortallity (0 to 30 days · adults undergoing cardiac surgery without cardiopulmonary bypass
It is very uncertain whether epidural analgesia changes mortallity (0 to 30 days compared with peripheral nerve blocks (very low certainty).
1 finding from 1 review
Block duration (0 to 1 day) · children (≤ 18 years of age) undergoing any type of surgical procedure (open or laparoscopic) for which a neuraxial (spinal, epidural,…
1 finding from 1 review
Length of hospital stay · adults receiving intravenous fluids while undergoing major non‐cardiac surgery
It is very uncertain whether perioperative restrictive fluid therapy changes length of hospital stay (days) compared with goal‐directed fluid therapy (very low certainty).
1 finding from 1 review
Time to first mobilisation · children having undergone thoraco‐lumbar spine surgery. 3 trials included in the analysis contained participants older than 18 years:…
1 finding from 1 review
Length of hospital stay · children having undergone thoraco‐lumbar spine surgery. 3 trials included in the analysis contained participants older than 18 years:…
1 finding from 1 review
Intervention not reported
All‐cause mortality (within 30 days) · adults undergoing cardiac surgery under general anaesthesia
The intervention showed no clear difference in all‐cause mortality (within 30 days) (low certainty).
1 finding from 1 review
Intervention not reported
Acute myocardial infarction (within 30 days) · adults undergoing cardiac surgery under general anaesthesia
The intervention showed no clear difference in acute myocardial infarction (within 30 days) (low certainty).
1 finding from 1 review
Intervention not reported
Cerebrovascular events (within 30 days) · adults undergoing cardiac surgery under general anaesthesia
It is very uncertain whether the intervention changes cerebrovascular events (within 30 days) (very low certainty).
1 finding from 1 review
Intervention not reported
Ventricular arrhythmias (within 30 days) · adults undergoing cardiac surgery under general anaesthesia
The intervention may leads to lower ventricular arrhythmias (within 30 days) (low certainty).
1 finding from 1 review
Intervention not reported
Atrial fibrillation or flutter, or both (within 30 days) · adults undergoing cardiac surgery under general anaesthesia
The intervention may leads to lower atrial fibrillation or flutter, or both (within 30 days) (low certainty).
1 finding from 1 review
Intervention not reported
Bradycardia (within 30 days; as defined by study authors, minimum heart rate < 60 beats per minute or requiring medication) · adults undergoing cardiac surgery under general anaesthesia
The intervention showed no clear difference in bradycardia (within 30 days; as defined by study authors, minimum… (low certainty).
1 finding from 1 review
Intervention not reported
Hypotension (within 30 days; as defined by study authors, minimum systolic blood pressure < 90 mmHg or requiring medication) · adults undergoing cardiac surgery under general anaesthesia
The intervention showed no clear difference in hypotension (within 30 days; as defined by study authors, minimum… (low certainty).
1 finding from 1 review
Early all‐cause mortality (within 30 days) · adults undergoing non‐cardiac surgery under general anaesthesia (to include: low‐risk, medium‐risk, and high‐risk surgeries)
Perioperative beta‐blockers showed no clear difference in early all‐cause mortality (within 30 days) compared with placebo or standard care (low certainty).
1 finding from 1 review
Myocardial infarction (0 to 30 days) · adults undergoing non‐cardiac surgery under general anaesthesia (to include: low‐risk, medium‐risk, and high‐risk surgeries)
Perioperative beta‐blockers may leads to lower acute myocardial infarction (within 30 days) compared with placebo or standard care (low certainty).
1 finding from 1 review
Cerebrovascular events (within 30 days) · adults undergoing non‐cardiac surgery under general anaesthesia (to include: low‐risk, medium‐risk, and high‐risk surgeries)
Perioperative beta‐blockers showed no clear difference in cerebrovascular events (within 30 days) compared with placebo or standard care (low certainty).
1 finding from 1 review
Ventricular arrhythmias (within 30 days) · adults undergoing non‐cardiac surgery under general anaesthesia (to include: low‐risk, medium‐risk, and high‐risk surgeries)
It is very uncertain whether perioperative beta‐blockers changes ventricular arrhythmias (within 30 days) compared with placebo or standard care (very low certainty).
1 finding from 1 review
Atrial fibrillation or atrial flutter, or both (within 30 days) · adults undergoing non‐cardiac surgery under general anaesthesia (to include: low‐risk, medium‐risk, and high‐risk surgeries)
Perioperative beta‐blockers may leads to lower atrial fibrillation or atrial flutter, or both (within 30 days) compared with placebo or standard care (low certainty).
1 finding from 1 review